Cargando…

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity

NK cells detect tumors through activating surface receptors, which bind self-antigens that are frequently expressed upon malignant transformation. To increase the recognition of tumor cells, the extracellular domains of ligands of the activating NK cell receptors NKp30, NKp80 and DNAM-1 (i.e. B7-H6,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peipp, Matthias, Derer, Stefanie, Lohse, Stefan, Staudinger, Matthias, Klausz, Katja, Valerius, Thomas, Gramatzki, Martin, Kellner, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741660/ https://www.ncbi.nlm.nih.gov/pubmed/26392331

Ejemplares similares

Promoting natural killer cell functions by recombinant immunoligands mimicking an induced self phenotype
por: Kellner, Christian, et al.
Publicado: (2013)

NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats
por: Lipinski, Britta, et al.
Publicado: (2023)

Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30
por: Luczo, Jasmina M., et al.
Publicado: (2021)

Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin
por: Jarahian, Mostafa, et al.
Publicado: (2011)

Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44
por: Byrd, Andreina, et al.
Publicado: (2007)

NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization
por: Hadad, Uzi, et al.
Publicado: (2015)

NKp46 defines ovine cells that have characteristics corresponding to NK cells
por: Connelley, Timothy, et al.
Publicado: (2011)

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
por: Garcia-Iglesias, Trinidad, et al.
Publicado: (2009)

Functional Differences between Human NKp44(−) and NKp44(+) RORC(+) Innate Lymphoid Cells
por: Hoorweg, Kerim, et al.
Publicado: (2012)

Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk
por: Chinnery, Fay, et al.
Publicado: (2012)

GSK-3α Inhibition in Drug-Resistant CML Cells Promotes Susceptibility to NK Cell-Mediated Lysis in an NKG2D- and NKp30-Dependent Manner
por: Kim, Nayoung, et al.
Publicado: (2021)

NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease
por: Ghadially, Hormas, et al.
Publicado: (2014)

NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans
por: Parodi, Monica, et al.
Publicado: (2019)

Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
por: Han, Bin, et al.
Publicado: (2018)

B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines
por: Banu, Nehla, et al.
Publicado: (2020)

A NKp80-Based Identification Strategy Reveals that CD56(neg) NK Cells Are Not Completely Dysfunctional in Health and Disease
por: Orrantia, Ane, et al.
Publicado: (2020)

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression
por: Glasner, Ariella, et al.
Publicado: (2017)

Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma
por: Iraqi, Muhammed, et al.
Publicado: (2022)

Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells
por: Marafini, Irene, et al.
Publicado: (2016)

NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint
por: Shemesh, Avishai, et al.
Publicado: (2016)

A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells
por: Bowen, Kelly E., et al.
Publicado: (2018)

NKp46 regulates allergic responses
por: Ghadially, Hormas, et al.
Publicado: (2013)

Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
por: Ferlazzo, Guido, et al.
Publicado: (2002)

Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1
por: Walwyn-Brown, Katherine, et al.
Publicado: (2018)

Development and characterisation of NKp44‐based chimeric antigen receptors that confer T cells with NK cell‐like specificity
por: Kasahara, Yasushi, et al.
Publicado: (2020)

Activatory Receptor NKp30 Predicts NK Cell Activation During Controlled Human Malaria Infection
por: Walk, Jona, et al.
Publicado: (2019)

Evaluation of NKp46 expression and cytokine production of decidual NK cells in women with recurrent pregnancy loss
por: Yamamoto, Mayu, et al.
Publicado: (2022)

Dependence of innate lymphoid cell 1 development on NKp46
por: Wang, Yufeng, et al.
Publicado: (2018)

NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death
por: Shemesh, Avishai, et al.
Publicado: (2018)

Direct Recognition of Fusobacterium nucleatum by the NK Cell Natural Cytotoxicity Receptor NKp46 Aggravates Periodontal Disease
por: Chaushu, Stella, et al.
Publicado: (2012)

Porcine CD8α(dim/-)NKp46(high) NK cells are in a highly activated state
por: Mair, Kerstin H, et al.
Publicado: (2013)

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

A NOVEL B7H3/NKP30 BISPECIFIC NK CELL ENGAGER FOR CANCER IMMUNOTHERAPY
por: Jiang, Xiaoling, et al.
Publicado: (2023)

Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy
por: Klausz, Katja, et al.
Publicado: (2020)

Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells
por: Lutz, Sebastian, et al.
Publicado: (2023)

The transcription factor HIF-1α mediates plasticity of NKp46(+) innate lymphoid cells in the gut
por: Krzywinska, Ewelina, et al.
Publicado: (2022)

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries
por: Klausz, Katja, et al.
Publicado: (2017)

Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé)
por: Glasner, Ariella, et al.
Publicado: (2017)

Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3
por: Arulanandam, Antonio, et al.
Publicado: (2023)

Understanding the Synergy of NKp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy
por: Zamai, Loris, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l4n0cdkvs46g1gt8fqkg73iqom